Turkey Regulatory Update: Faster Approvals and Better Access
This article was originally published in PharmAsia News
Executive Summary
The registration process in Turkey for selected new drugs is to be accelerated, while patients are starting to receive their cancer treatments from hospitals under a new system. Meanwhile more than 100 drugs remain inaccessible to Turkish patients and an influential academician has warned against hepatitis A vaccines produced in China.